Sector Update: Healthcare Shares Mixed in Pre-Market Trade; Pfizer Subsidiary Ends License Deal with Acura

By
A A A

Top Healthcare stocks:

JNJ: -0.03%

PFE: -0.16%

ABT: flat

MRK: +1.23%

AMGN: -0.34

Healthcare shares were generally mixed in pre-market trade on Wednesday.

In healthcare stocks news, pharmaceutical giant Bristol-Myers Squibb ( BMY ) released encouraging Phase 3 data from its study investigating the all-oral, interferon- and ribavirin-free regimen of daclatasvir and asunaprevir among genotype 1b hepatitis C virus or HCV-infected patients.

And, Pfizer ( PFE ) said its subsidiary, King Pharmaceuticals Research & Development and specialty pharmaceutical company Acura Pharmaceuticals ( ACUR ) said Thursday that they will be terminating their license, development and commercialization agreement covering ACUR's proprietary drug abuse deterrent and tamper-resistant technologies, AVERSION and OXECTA.

PFE shares were down 0.16% at $31.25, with a 52-week range of $27.12 - $32.96.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: BMY , PFE , ACUR

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

24,816,666
  • $103.50 ▲ 0.98%
23,585,783
  • $10.48 ▲ 12.09%
21,945,368
  • $16.1501 ▲ 0.37%
17,718,909
  • $19.91 ▲ 1.74%
15,846,661
  • $12.54 ▲ 7.36%
14,825,613
  • $50.97 ▲ 2.45%
14,387,253
    $3.63 unch
13,803,438
  • $75.6218 ▲ 1.07%
As of 9/2/2014, 11:41 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com